Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China
· Delayed Price · Currency is CNY 60.39
-0.06 (-0.10%)
At close: May 16, 2025, 2:57 PM CST
Hangzhou AGS MedTech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 296.86 | 293.39 | 217.24 | 144.96 | 104.8 | 45.23 | Upgrade
|
| Depreciation & Amortization | 8.85 | 8.85 | 6.56 | 6.26 | 4.4 | 3.36 | Upgrade
|
| Other Amortization | 1.2 | 1.2 | 1.14 | 1.44 | 1.96 | 1.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.19 | 0.19 | 0.35 | 0.14 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.46 | 1.96 | 1.01 | 0.34 | Upgrade
|
| Loss (Gain) From Sale of Investments | -21.63 | -21.63 | -2.11 | 7.19 | -1.72 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.5 | -0.5 | 2.15 | - | - | - | Upgrade
|
| Other Operating Activities | -8.76 | 1.46 | 1.81 | -11.53 | 4.73 | 5.24 | Upgrade
|
| Change in Accounts Receivable | 9.42 | 9.42 | -39.77 | -8.19 | 0.08 | 3.3 | Upgrade
|
| Change in Inventory | -13.61 | -13.61 | -12.67 | -1.28 | -22.19 | -1.97 | Upgrade
|
| Change in Accounts Payable | 32.44 | 32.44 | 45.44 | 15.7 | 25.06 | -3.84 | Upgrade
|
| Change in Other Net Operating Assets | 3.91 | 3.91 | 2.4 | - | - | - | Upgrade
|
| Operating Cash Flow | 309.05 | 315.8 | 221.45 | 156.38 | 118.25 | 53.36 | Upgrade
|
| Operating Cash Flow Growth | 37.36% | 42.60% | 41.61% | 32.24% | 121.61% | 11.14% | Upgrade
|
| Capital Expenditures | -41.16 | -49.6 | -51.57 | -60.12 | -15.66 | -28.25 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.08 | 0.03 | 0 | - | Upgrade
|
| Investment in Securities | -1,081 | -1,081 | -25.3 | -55 | - | - | Upgrade
|
| Other Investing Activities | 35.25 | - | - | -3.51 | 0.37 | -1.93 | Upgrade
|
| Investing Cash Flow | -1,087 | -1,130 | -76.79 | -118.6 | -15.29 | -30.18 | Upgrade
|
| Long-Term Debt Repaid | - | -0.85 | -1.18 | -1.52 | -0.67 | - | Upgrade
|
| Total Debt Repaid | -0.85 | -0.85 | -1.18 | -1.52 | -0.67 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.85 | -0.85 | -1.18 | -1.52 | -0.67 | - | Upgrade
|
| Issuance of Common Stock | 5.87 | 5.87 | 1,820 | - | - | - | Upgrade
|
| Repurchase of Common Stock | -30.97 | -30.97 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -83.33 | -83.33 | -43.98 | -35.95 | -49.05 | - | Upgrade
|
| Other Financing Activities | 20.33 | - | -177.6 | -1.15 | - | - | Upgrade
|
| Financing Cash Flow | -88.94 | -109.28 | 1,598 | -38.62 | -49.72 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.1 | 0.32 | 0.65 | 9.45 | -4.75 | -5.38 | Upgrade
|
| Net Cash Flow | -866.45 | -923.51 | 1,743 | 8.62 | 48.5 | 17.8 | Upgrade
|
| Free Cash Flow | 267.89 | 266.19 | 169.88 | 96.26 | 102.59 | 25.11 | Upgrade
|
| Free Cash Flow Growth | 53.49% | 56.70% | 76.48% | -6.17% | 308.62% | -36.51% | Upgrade
|
| Free Cash Flow Margin | 40.98% | 41.81% | 33.39% | 25.94% | 33.59% | 14.60% | Upgrade
|
| Free Cash Flow Per Share | 3.32 | 3.30 | 2.34 | 1.58 | 1.69 | 0.41 | Upgrade
|
| Cash Income Tax Paid | 75.35 | 72.45 | 42.18 | 19.73 | 17.57 | 14.93 | Upgrade
|
| Levered Free Cash Flow | 107.91 | 159.65 | 79.69 | 56.73 | 68.87 | 4.63 | Upgrade
|
| Unlevered Free Cash Flow | 107.92 | 159.65 | 79.69 | 56.73 | 68.87 | 4.63 | Upgrade
|
| Change in Net Working Capital | 47.17 | -18.76 | 15.27 | -15.34 | -4.99 | 1.63 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.